Literature DB >> 20442286

Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro.

Dave N T Aryee1, Stephan Niedan, Maximilian Kauer, Raphaela Schwentner, Idriss M Bennani-Baiti, Jozef Ban, Karin Muehlbacher, Michael Kreppel, Robert L Walker, Paul Meltzer, Christopher Poremba, Reinhard Kofler, Heinrich Kovar.   

Abstract

Hypoxia is an important condition in the tumor cell microenvironment and approximately 1% to 1.5% of the genome is transcriptionally responsive to hypoxia with hypoxia-inducible factor-1 (HIF-1) as a major mediator of transcriptional activation. Tumor hypoxia is associated with a more aggressive phenotype of many cancers in adults, but data on pediatric tumors are scarce. Because, by immunohistochemistry, HIF-1alpha expression was readily detectable in 18 of 28 primary Ewing's sarcoma family tumors (ESFT), a group of highly malignant bone-associated tumors in children and young adults, we studied the effect of hypoxia on ESFT cell lines in vitro. Intriguingly, we found that EWS-FLI1 protein expression, which characterizes ESFT, is upregulated by hypoxia in a HIF-1alpha-dependent manner. Hypoxia modulated the EWS-FLI1 transcriptional signature relative to normoxic conditions. Both synergistic as well as antagonistic transcriptional effects of EWS-FLI1 and of hypoxia were observed. Consistent with alterations in the expression of metastasis-related genes, hypoxia stimulated the invasiveness and soft agar colony formation of ESFT cells in vitro. Our data represent the first transcriptome analysis of hypoxic ESFT cells and identify hypoxia as an important microenvironmental factor modulating EWS-FLI1 expression and target gene activity with far-reaching consequences for the malignant properties of ESFT. (c)2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20442286      PMCID: PMC2884367          DOI: 10.1158/0008-5472.CAN-09-4333

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  47 in total

Review 1.  Potentials for RNAi in sarcoma research and therapy: Ewing's sarcoma as a model.

Authors:  Heinrich Kovar; Josef Ban; Sarka Pospisilova
Journal:  Semin Cancer Biol       Date:  2003-08       Impact factor: 15.707

2.  EWS/FLI function varies in different cellular backgrounds.

Authors:  Jeffrey P Zwerner; Jennifer Guimbellot; William A May
Journal:  Exp Cell Res       Date:  2003-11-01       Impact factor: 3.905

3.  Anchorage-independent multi-cellular spheroids as an in vitro model of growth signaling in Ewing tumors.

Authors:  Elizabeth R Lawlor; Christina Scheel; Julia Irving; Poul H B Sorensen
Journal:  Oncogene       Date:  2002-01-10       Impact factor: 9.867

Review 4.  Hypoxia--a key regulatory factor in tumour growth.

Authors:  Adrian L Harris
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

5.  Hypoxia actively represses transcription by inducing negative cofactor 2 (Dr1/DrAP1) and blocking preinitiation complex assembly.

Authors:  Nicholas Denko; Kara Wernke-Dollries; Amber Buescher Johnson; Ester Hammond; Cheng-Ming Chiang; Michelle Craig Barton
Journal:  J Biol Chem       Date:  2002-12-10       Impact factor: 5.157

Review 6.  Investigating hypoxic tumor physiology through gene expression patterns.

Authors:  Nicholas C Denko; Lucrezia A Fontana; Karen M Hudson; Patrick D Sutphin; Soumya Raychaudhuri; Russ Altman; Amato J Giaccia
Journal:  Oncogene       Date:  2003-09-01       Impact factor: 9.867

Review 7.  O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1.

Authors:  Gregg L Semenza
Journal:  J Appl Physiol (1985)       Date:  2004-03

8.  Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells.

Authors:  Tomomi Kitamuro; Kazuhiro Takahashi; Kazuhiro Ogawa; Reiko Udono-Fujimori; Kazuhisa Takeda; Kazumichi Furuyama; Masaharu Nakayama; Jiying Sun; Hiroyoshi Fujita; Wataru Hida; Toshio Hattori; Kunio Shirato; Kazuhiko Igarashi; Shigeki Shibahara
Journal:  J Biol Chem       Date:  2003-01-02       Impact factor: 5.157

Review 9.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

10.  PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.

Authors:  Vamsi K Mootha; Cecilia M Lindgren; Karl-Fredrik Eriksson; Aravind Subramanian; Smita Sihag; Joseph Lehar; Pere Puigserver; Emma Carlsson; Martin Ridderstråle; Esa Laurila; Nicholas Houstis; Mark J Daly; Nick Patterson; Jill P Mesirov; Todd R Golub; Pablo Tamayo; Bruce Spiegelman; Eric S Lander; Joel N Hirschhorn; David Altshuler; Leif C Groop
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

View more
  39 in total

1.  Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma.

Authors:  Idriss M Bennani-Baiti; Aaron Cooper; Elizabeth R Lawlor; Maximilian Kauer; Jozef Ban; Dave N T Aryee; Heinrich Kovar
Journal:  Clin Cancer Res       Date:  2010-06-04       Impact factor: 12.531

Review 2.  Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.

Authors:  Adwitiya Kar; Arthur Gutierrez-Hartmann
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-09-25       Impact factor: 8.250

3.  In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis.

Authors:  Sung-Hyeok Hong; Jason U Tilan; Susana Galli; Rachel Acree; Katherine Connors; Akanksha Mahajan; Larissa Wietlisbach; Taylor Polk; Ewa Izycka-Swieszewska; Yi-Chien Lee; Luciane R Cavalli; Olga C Rodriguez; Chris Albanese; Joanna B Kitlinska
Journal:  J Vis Exp       Date:  2016-12-09       Impact factor: 1.355

4.  Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma.

Authors:  J Ban; G Jug; P Mestdagh; R Schwentner; M Kauer; D N T Aryee; K-L Schaefer; F Nakatani; K Scotlandi; M Reiter; D Strunk; F Speleman; J Vandesompele; H Kovar
Journal:  Oncogene       Date:  2011-01-10       Impact factor: 9.867

Review 5.  Hypoxia, stem cells and bone tumor.

Authors:  Wen Zeng; Rong Wan; Yuehuan Zheng; Shree Ram Singh; Yiyong Wei
Journal:  Cancer Lett       Date:  2011-09-29       Impact factor: 8.679

6.  Hypoxia-inducible factor (HIF)-1α and CCN2 form a regulatory circuit in hypoxic nucleus pulposus cells: CCN2 suppresses HIF-1α level and transcriptional activity.

Authors:  Cassie M Tran; Nobuyuki Fujita; Bau-Lin Huang; Jessica R Ong; Karen M Lyons; Irving M Shapiro; Makarand V Risbud
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

7.  Prognostic profiling of the immune cell microenvironment in Ewing´s Sarcoma Family of Tumors.

Authors:  David Stahl; Andrew J Gentles; Ralf Thiele; Ines Gütgemann
Journal:  Oncoimmunology       Date:  2019-10-13       Impact factor: 8.110

Review 8.  Signaling mechanisms of the epithelial-mesenchymal transition.

Authors:  David M Gonzalez; Damian Medici
Journal:  Sci Signal       Date:  2014-09-23       Impact factor: 8.192

Review 9.  Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology.

Authors:  Jason Tilan; Joanna Kitlinska
Journal:  Neuropeptides       Date:  2015-10-26       Impact factor: 3.286

10.  Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.

Authors:  Xiang Nan; Jiang Wang; Hao Cheng; Zheng Yin; Jianting Sheng; Bensheng Qiu; Ching C Lau; Jason T Yustein; Hong Zhao; Stephen T C Wong
Journal:  Cancer Lett       Date:  2019-10-28       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.